z-logo
open-access-imgOpen Access
Ischemic stroke associated with anticardiolipin antibodies.
Author(s) -
Steven R. Levine,
S. Kim,
M. J. Deegan,
K.M.A. Welch
Publication year - 1987
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.18.6.1101
Subject(s) - medicine , lupus anticoagulant , anticardiolipin antibodies , autoantibody , stroke (engine) , systemic lupus erythematosus , antibody , cerebral infarction , antiphospholipid syndrome , immunology , systemic disease , ischemic stroke , anticoagulant , connective tissue disease , autoimmune disease , immunopathology , disease , ischemia , mechanical engineering , engineering
Anticardiolipin antibodies are a group of antiphospholipid autoantibodies seen primarily in patients with systemic lupus erythematosus and other autoimmune diseases. We report 3 patients, 2 without systemic lupus, who suffered ischemic brain infarction associated with these antibodies in the absence of detectable lupus anticoagulant activity. Anticardiolipin antibodies, possibly associated with a lupus anticoagulant-like thrombotic tendency, may be a newly recognized cause of ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom